Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.290
-0.050 (-3.73%)
Feb 11, 2026, 4:00 PM EST - Market closed

RANI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1574686146322-
Market Cap Growth
229.09%-46.89%-41.09%-54.75%--
Enterprise Value
1715273107273-
Last Close Price
1.341.373.325.9016.35-
PS Ratio
41.6744.39--118.62-
PB Ratio
-13.073.381.972.65-
P/TBV Ratio
-22.916.683.966.80-
EV/Sales Ratio
142.3250.21--100.44-
Debt / Equity Ratio
-1.478.511.180.41-0.05
Asset Turnover
0.050.02--0.030.01
Quick Ratio
0.221.416.1020.4544.4913.76
Current Ratio
0.261.506.3720.9645.3014.12
Return on Equity (ROE)
--391.10%-136.52%-64.78%-54.94%-36.62%
Return on Assets (ROA)
-95.52%-65.57%-49.79%-34.15%-31.68%-20.19%
Return on Capital Employed (ROCE)
455.50%-296.20%-132.40%-61.50%-42.40%-22.30%
Earnings Yield
-17.99%-65.78%-39.54%-20.97%-2.58%-
FCF Yield
-17.65%-78.37%-61.06%-33.00%-10.16%-
Buyback Yield / Dilution
-39.37%-11.65%-7.09%-21.93%58.34%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q